Search
Program Calendar
Browse By Day
Browse By Time
Browse By Person
Browse By Session Type
Browse By Topic
Personal Schedule
Sign In
Deadlines
Policies
Updating Your Submission
Requesting AV
Presentation Tips
Request a Visa Letter
FAQs
X (Twitter)
Search Tips
Annual Meeting App
About Annual Meeting
This article examines how the voices of different constituency groups are shaped within regulatory spaces where women's health issues are debated. We analyze over 350 pages of transcripts of a 2-day hearing in September 2011, wherein the FDA reviewed the safety and efficacy of vaginal mesh devices. We analyze the claims each group made and their basis of knowledge, and consider how the hearing’s structure shaped participation. The claimants, women injured by mesh, rely on embodied knowledge, using the voice of the lifeworld to convey meanings of mesh-induced adverse events and to critique regulatory lapses. Physicians use the voice of medicine, which, rather than being strictly scientific, is shaped by clinical knowledge and patient interactions. Industry and FDA representatives rely on scientific knowledge, which makes a claim to objective authority, but which also serves a commercial functionality. We find that the structure of the proceedings privileges the voice of science above all others, and results in a regulatory scripting that ultimately silences the voice of the lifeworld.